Game-Changer for Canine Cancer: ELIAS Announces Key Hire Ahead of Revolutionary Treatment Launch

ELIAS Animal Health appoints Brian Segebrecht as Chief Revenue Officer, gearing up for the Q4 launch of their groundbreaking ELIAS Cancer Immunotherapy (ECI®) for dogs. This innovative treatment promises to redefine cancer care in pets, filling a crucial gap in existing treatment options and offering new hope for managing canine osteosarcoma.